Siga Technologies (SIGA) Liabilities and Shareholders Equity (2010 - 2025)
Siga Technologies (SIGA) reported Liabilities and Shareholders Equity of $219.5 million for Q4 2025, down 10.18% on a YoY basis from $244.3 million in Q4 2024, and down 5.24% quarter-over-quarter from $231.6 million in Q3 2025.
Siga Technologies (SIGA) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends
Siga Technologies has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $219.5 million in Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 10.18% year-over-year to $219.5 million; the trailing twelve-month figure through Dec 2025 stood at $933.5 million (up 6.62% YoY), and the FY2025 full-year result was $219.5 million, down 10.18% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $219.5 million, down from $231.6 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $254.4 million in Q4 2023, with the low at $133.7 million in Q2 2021.
- Historically, Liabilities and Shareholders Equity has averaged $195.9 million across 5 years, with a median of $195.2 million in 2022.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 50.65% — and 2023, when it fell 22.45%.
- Siga Technologies' Liabilities and Shareholders Equity stood at $214.7 million in 2021, then declined by 9.17% to $195.0 million in 2022, then surged by 30.41% to $254.4 million in 2023, then slipped by 3.94% to $244.3 million in 2024, then declined by 10.18% to $219.5 million in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $219.5 million (Q4 2025), $231.6 million (Q3 2025), and $235.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.27 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.35 Bn |
| 10 | Siga Technologies | 314.73 Mn | 159.77 Mn | - | 219.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 219.47 Mn |
| Sep 30, 2025 | 231.60 Mn |
| Jun 30, 2025 | 235.33 Mn |
| Mar 31, 2025 | 247.07 Mn |
| Dec 31, 2024 | 244.34 Mn |
| Sep 30, 2024 | 195.35 Mn |
| Jun 30, 2024 | 192.66 Mn |
| Mar 31, 2024 | 243.15 Mn |
| Dec 31, 2023 | 254.35 Mn |
| Sep 30, 2023 | 158.38 Mn |
| Jun 30, 2023 | 146.51 Mn |
| Mar 31, 2023 | 183.92 Mn |
| Dec 31, 2022 | 195.04 Mn |
| Sep 30, 2022 | 204.22 Mn |
| Jun 30, 2022 | 159.94 Mn |
| Mar 31, 2022 | 184.55 Mn |
| Dec 31, 2021 | 214.73 Mn |
| Sep 30, 2021 | 135.56 Mn |
| Jun 30, 2021 | 133.69 Mn |
| Mar 31, 2021 | 138.77 Mn |